Boothbay Fund Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$598K Buy
8,883
+4,397
+98% +$293K 0.01% 1384
2026
Q1
$282K Buy
+4,486
New +$312K ﹤0.01% 1633
2025
Q4
Sell
-3,203
Closed -$207K 2061
2025
Q3
$216K Buy
+3,203
New +$253K ﹤0.01% 1616
2025
Q1
Sell
-15,361
Closed -$1.19M 1496
2024
Q4
$1.19M Buy
15,361
+1,308
+9% +$96.8K 0.03% 590
2024
Q3
$942K Sell
14,053
-19,074
-58% -$1.57M 0.02% 775
2024
Q2
$3.76M Buy
33,127
+19,398
+141% +$2.45M 0.09% 308
2024
Q1
$1.9M Buy
+13,729
New +$1.73M 0.04% 527
2023
Q4
Sell
-63,677
Closed -$5.94M 1731
2023
Q3
$5.94M Buy
63,677
+60,397
+1,841% +$6.81M 0.14% 170
2023
Q2
$422K Buy
+3,280
New +$397K 0.01% 1177
2022
Q2
Sell
-6,476
Closed -$828K 2353
2022
Q1
$828K Sell
6,476
-200
-3% -$21.9K 0.02% 1017
2021
Q4
$896K Buy
6,676
+3,780
+131% +$543K 0.02% 801
2021
Q3
$396K Buy
+2,896
New +$365K 0.01% 1201
2020
Q2
Sell
-5,896
Closed -$397K 1006
2020
Q1
$397K Buy
+5,896
New +$367K 0.03% 496
2017
Q1
Sell
-17,208
Closed -$257K 788
2016
Q4
$257K Buy
+17,208
New +$305K 0.06% 472

Other funds holding DXCM

Boothbay Fund Management's DXCM Position: Q2 2026 in Review

Boothbay Fund Management increased its DexCom (DXCM) stake by 98% in Q2 2026, buying an estimated $293K and bringing the position to 8,883 shares worth $598K. The position accounts for 0.01% of the portfolio, ranked #1384.

Boothbay Fund Management first reported a position in DXCM in Q4 2016 and has held it in 14 quarters since. The position peaked at $5.94M in Q3 2023. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Boothbay Fund Management held 8,883 shares of DexCom worth $598K as of Q2 2026.
  • Boothbay Fund Management bought 4,397 DexCom shares in Q2 2026, an estimated $293K.
  • DexCom made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1384 holding.
  • Boothbay Fund Management first reported a position in DexCom in Q4 2016 and has held it in 14 quarters since.
  • Boothbay Fund Management's DexCom position peaked at $5.94M in Q3 2023.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.